Skip to main content
Log in

A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The authors report the results of a randomized study in which comparison was made between two different kinds of treatment in patients affected by uncomplicated duodenal ulcer endoscopically diagnosed. The first group was treated with 1 g of cimetidine per day, during a period of four weeks (200 mg three times a day and 400 mg at bedtime); the second with a liquid Al−Mg antacid compound, 210 ml/day (30 ml, 1 and 3 hr after meals and 30 ml before bedtime) for four weeks. Fifty-one patients were studied, 27 treated with cimetidine, 24 with antacids. At the end of the four-week period, 21 patients (77.7%) in the cimetidine group and 18 patients (75%) in the antacid group were completely healed. Benign side effects were remarked in both types of treatment, none of which made it necessary to suspend treatment. No significant variation of the basal and peak acid output before and after each kind of treatment was observed, while a slight but significant increase in fasting serum gastrin concentration was noted after treatment in the antacid group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aadland E, Berstad A, Semb LS: Inhibition of pentagastrinstimulated gastric secretion by cimetidine in healthy subjects.In Proceedings of 2nd International Symposium on Histamine H2-Receptor Antagonists. WL Burland, MA Simkins (eds). Amsterdam, Excerpta Medica, 1977, pp 87–97

    Google Scholar 

  2. Gilbert O, Barbezat Simmy Bank: Basal acid output response to cimetidine in man.In Proceedings of 2nd International Symposium on Histamine H2-Receptor Antagonists. WL Burland, MA Simkins (eds). Amsterdam, Excerpta Medica, 1977, pp 110–119

    Google Scholar 

  3. Pounder RE, Williams JG, Hunt RH, Vincent SH, Milton-Thompson GJ, Misiewicz JJ: The effects of oral cimetidine on food-stimulated gastric acid secretion and 24-hour intragastric acidity.In Proceedings of 2nd International Symposium on Histamine H2-Receptor Antagonists. WL Burland, MA Simkins (eds). Amsterdam, Excerpta Medica, 1977, pp 189–203

    Google Scholar 

  4. Henn RM, Isemberg JI, Vernon Maxwell BS, Sturdevant RAL: Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer. N Engl J Med 293:371–375, 1975

    Google Scholar 

  5. Longstreth GF, Go VLW, Malagelada JR: Cimetidine suppression of nocturnal gastric secretion in active duodenal ulcer. N Engl J Med 294:801–804, 1976

    Google Scholar 

  6. Sewing KF, Hagie L, Ippoliti AF, Isemberg JI, Samloff IM, Sturdevant RAL: Effect of one-month treatment with cimetidine on gastric secretion and serum gastrin and pepsinogen levels. Gastroenterology 74 (Suppl):376–379, 1978

    Google Scholar 

  7. Bank S, Barbezat GO, Novis BH: Histamine H2-receptor antagonists in the treatment of duodenal ulcer. S Afr Med J 50:1781–1785, 1976

    Google Scholar 

  8. Blackwood WS, Pickard RG, Maudgal DP, Lawrence D, Northfield TC: Cimetidine in duodenal ulcer. A controlled trial. Lancet 2:174–176, 1976

    Google Scholar 

  9. Bodemar G, Walan A: Cimetidine in the treatment of active duodenal and prepyloric ulcers, Lancet 2:161–164, 1976

    Google Scholar 

  10. Hetzel DJ, Hansky J, Shearman DJC, Korman MG, Hecher R, Taggart GJ, Jackson R, Gabb BW: Cimetidine treatment of duodenal ulceration. Short-term clinical trial and maintenance study. Gastroenterology 74 (Suppl):389–392, 1978

    Google Scholar 

  11. Semb LS, Berstad A, Myren J, Foss JC, Carlsen E, Kruse-Jensen A: A double-blind multicentre comparative study of cimetidine and placebo in short-term treatment of active duodenal ulceration.In Proceedings of 2nd International Symposium on Histamine H2-Receptor Antagonists. WL Burland, MA Simkins (eds). Amsterdam, Excerpta Medica, 1977, pp 248–253

    Google Scholar 

  12. Gillespie G, Gray GR, Smith IS, Mackenzie I, Crean GP: Short-term and maintenance cimentidine treatment in severe duodenal ulceration.In Proceedings of 2nd International Symposium on Histamine H2-Receptor Antagonists, WL Burland, MA Simkins (eds) Amsterdam, Excerpta Medica, 1977, pp 240–247

    Google Scholar 

  13. Bardhan KD, Saul DM, Balmforth GV, Maruyama T, Duthie HL, Fussey IV, Heading RC, Fettes M, Logan RFA, Holdsworth CD, Langman MJ, Dronfield MW, Larkworty W, Smith PM, Edwards JL, Wyllie JH, Haggie SJ, Hawkins BW: The effect of cimetidine on duodenal ulceration. An interim report of a multicentre double-blind trial.In Proceedings of 2nd International Symposium on Histamine H2-Receptor Antagonists. WL Burland, MA Simkins (eds). Amsterdam, Excerpta Medica, 1977, pp 260–271

    Google Scholar 

  14. Binder HJ, Cocco A, Crossley RJ, Finkelstein W, Font R, Friedman G, Groarke J, Hughes W, Johnson AF, McGuigan JE, Summers R, Vlahcevic R, Wilson EC, Winship DH: Cimetidine in the treatment of duodenal ulcer. A multicentre double-blind study. Gastroenterology 74 (Suppl):380–388, 1978

    Google Scholar 

  15. Fordtran JS, Collyns JAH: Antacid pharmacology in duodenal ulcer: effects of antacids on postcibal gastric acidity and peptic activity. N Engl J Med 274:921–927, 1966

    Google Scholar 

  16. Fordtran JS, Morawski SG, Richardson CT:In vivo andin vitro evaluation of liquid antacids. N Engl J Med 288:923–928, 1973

    Google Scholar 

  17. Deering TB, Malagelada JR: Comparison of an H2-receptor antagonist and a neutralizing antacid on postprandial acid delivery into the duodenum in patients with duodenal ulcer. Gastroenterology 73:11–14, 1977

    Google Scholar 

  18. Peterson WL, Sturdevant RAL, Frankl HD, Richardson CT, Isemberg JI, Elashoff JD, Sones JQ, Gross RA, McCallum RW, Fordtran JS: Healing of duodenal ulcer with an antacid regimen. N Engl J Med 297:341–345, 1977

    Google Scholar 

  19. Ippoliti AF, Sturdevant RAL, Isemberg JI, Binder M, Camacho R, Cano R, Cooney C, Kline MM, Koretz RL, Meyer JH, Samloff IM, Schwabe AD, Strom EA, Valenzuela JE, Wintroub RH: Cimetidine versus intensive antacid therapy for duodenal ulcer. A multicenter trial. Gastroenterology 74 (Suppl):393–395, 1978

    Google Scholar 

  20. Fordtran JS: Reduction of acidity by diet, antacids and anticholinergic agents. Gastrointestinal Disease. MH Sleisinger, JS Fordtran (eds). Philadelphia, WB Saunders, 1973, pp 718–742

    Google Scholar 

  21. Fedeli G, Anti M, Rapaccini GL: Erosive duodenitis during cimetidine treatment. Br Med J 1:853, 1978

    Google Scholar 

  22. Webster J, Petrie C, NAG Mowat: Erosive gastritis and duodenitis during continuous cimetidine treatment. Br Med J 1:20, 1978

    Google Scholar 

  23. Caldwell JH, Cline CT, Fox AW, Cataland S: Effect of chronic antacid ingestion on serum gastrin and acid secretion. Am J Dig Dis 21:863–866, 1976

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fedeli, G., Anti, M., Rapaccini, G.L. et al. A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer. Digest Dis Sci 24, 758–762 (1979). https://doi.org/10.1007/BF01317208

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01317208

Keywords

Navigation